Top Markets
#1 Pleasing Gold Pleasing Gold +1,548.36%
#2 PulseChain PulseChain +58.48%
#3 Merlin's Seal BTC Merlin's Seal BTC +32.56%
#4 Ontology Gas Ontology Gas +32.42%
#5 BOOK OF MEME BOOK OF MEME +30.49%
#6 Pump.fun Pump.fun +24.97%
#7 Unit Pump Unit Pump +24.97%
#8 Nockchain Nockchain +21.96%
#9 RSK Infrastructure Framework RSK Infrastructure Framework +21.19%
#10 Neiro Neiro +19.16%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Rank in Stocks #26767
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Share Price
$1.30
Last synced: 2023-10-13
Market Cap
$38.02M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Zynerba Pharmaceuticals, Inc. (ZYNE)

Category

Healthcare
Revenue for Zynerba Pharmaceuticals, Inc. (ZYNE)
Revenue in Aug 2026 TTM: 0
According to Zynerba Pharmaceuticals, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zynerba Pharmaceuticals, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN